Providing education, support, advocacy, and promoting research
for CTX patients, their families, and medical professionals
who treat and study this rare disease.
The onset of symptoms, specific symptoms, and progression of CTX varies greatly from one individual to another, even for twins with the same abnormality in the CYP27A1 gene (GeneReviews article).
Some children affected with CTX experience cholestatic jaundice during infancy. Affected individuals can experience diarrhea and cataracts in childhood and may develop xanthomas of the tendons during adolescence. Not every individual with CTX develops all of these signs and symptoms and the age at which they appear varies. Patients with CTX often experience a delay in diagnosis after the onset of first symptoms. If untreated, CTX can lead to progressive neurologic problems such as seizures, cognitive impairment, and difficulties with coordination and balance.
The signs and/or symptoms that may appear in adolescence and adulthood:
- Xanthomas: Skin lesions characterized by accumulations of lipid-laden cells.
- Spasticity
- Tremor, difficulty with fast limb movements, nystagmus (eyes moving back and forth), balance problems
- Neurologic dysfunction with variable time of onset (seizures, balance problems, difficulty walking, movement disorders, spasticity, impaired speech, and decreased sensation in arms and legs)
- Cataracts
- Chronic diarrhea
- Osteoporosis/fracture
- Psychiatric symptoms, including behavioral changes, hallucinations, agitation, and/or aggression
Common signs and/or symptoms that may appear in infancy and early childhood are:
- Liver Disease/jaundice
- Chronic Diarrhea
- Cataracts
- Cognitive Impairment
- Autism
- Impaired balance
- Movement disorders
Join The CTX Alliance
Join our mailing list to receive information and news as we begin to gather and expand the CTX community.
Support the CTX Alliance
1586 Sumneytown Pike
PO Box 1322
Kulpsville, PA 19443
info@ctxalliance.org
Latest CTX Articles
- Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomes November 18, 2021
- Cerebrotendinous Xanthomatosis September 13, 2021
- Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX) August 27, 2021